O
Ovid Therapeutics Inc.
OVID · NASDAQ · Healthcare · 528M
Closing price
$2.46
+5.13% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.4×
Enterprise value / EBITDAEV/EBITDA
-10.6×
Free cash flow yieldFCF yield
-21.1%
Return on equityROE
-13.3%
Operating margin
-585.2%
Net debt / EBITDAbalance-sheet strength
-0.0×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.